InvestorsHub Logo
Followers 42
Posts 2198
Boards Moderated 0
Alias Born 02/10/2014

Re: None

Thursday, 12/18/2014 7:43:21 PM

Thursday, December 18, 2014 7:43:21 PM

Post# of 2206
Very interesting post from Hotcopper ...

Joshua McCarroll and Maria Kavallaris have been extending B-III Tubulin studies using shRNA in other cancer indications.

This study shows significant reduction of tumours in mice. Might eventually be a very good program for BLT to take on if the NSCLC program shows promise.

http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=2946&path[]=5579
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News